Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,356 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class II · Moderate risk

Clear Eyes Assorted Sidekick Floor Stand Display

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1828-2019
Class II · Moderate risk

Clear Eyes Assorted IRC Display

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1826-2019
Class II · Moderate risk

Clear eyes MAXIMUM REDNESS RELIEF

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1825-2019
Class II · Moderate risk

Clear eyes MAXIMUM ITCHY EYE RELIEF

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1824-2019
Class II · Moderate risk

Clear eyes REDNESS RELIEF

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1823-2019
Class II · Moderate risk

Clear eyes REDNESS RELIEF

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1822-2019
Class II · Moderate risk

Mometasone Furoate Cream USP

GMP Deviations: Glenmark received complaints stating that mometasone fuorate cream was gritty.

Terminated cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-192-17 D-1586-2019
Class II · Moderate risk

Gentamicin

Lack of Processing Controls

Terminated cGMP deviation Wise Pharmacy D-1570-2019
Class II · Moderate risk

Fungo Off Capsules

CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.

Terminated cGMP deviation Herbal Doctor Remedies D-1629-2019
Class II · Moderate risk

Asma Stopper Capsules

CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.

Terminated cGMP deviation Herbal Doctor Remedies D-1628-2019
Class II · Moderate risk

Anemia Off

CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.

Terminated cGMP deviation Herbal Doctor Remedies D-1627-2019
Class II · Moderate risk

Appetrol Capsules

CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.

Terminated cGMP deviation Herbal Doctor Remedies D-1626-2019
Class II · Moderate risk

Mental Tonic Capsules

CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.

Terminated cGMP deviation Herbal Doctor Remedies D-1625-2019

Recalls by year